| Title : Preclinical and randomized clinical evaluation of the p38alpha kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration - Jiang_2022_Nat.Commun_13_5308 |
| Author(s) : Jiang Y , Alam JJ , Gomperts SN , Maruff P , Lemstra AW , Germann UA , Stavrides PH , Darji S , Malampati S , Peddy J , Bleiwas C , Pawlik M , Pensalfini A , Yang DS , Subbanna S , Basavarajappa BS , Smiley JF , Gardner A , Blackburn K , Chu HM , Prins ND , Teunissen CE , Harrison JE , Scheltens P , Nixon RA |
| Ref : Nat Commun , 13 :5308 , 2022 |
| Abstract : Jiang_2022_Nat.Commun_13_5308 |
| ESTHER : Jiang_2022_Nat.Commun_13_5308 |
| PubMedSearch : Jiang_2022_Nat.Commun_13_5308 |
| PubMedID: 36130946 |